| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
| mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
8e-08 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-07 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.2 |
3e-06 |